Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(2S)-2-PHENYL-4-OXOPYRROLIDINE, N-BOC PROTECTED is a chemical compound that serves as a building block in organic synthesis, characterized by its specific spatial arrangement of atoms as a stereoisomer and the protective N-BOC group for the amine functional group.

635724-46-8 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 635724-46-8 Structure
  • Basic information

    1. Product Name: (2S)-2-PHENYL-4-OXOPYRROLIDINE, N-BOC PROTECTED
    2. Synonyms: 4-OXO-2(S)-PHENYL-PYRROLIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER;(2S)-2-PHENYL-4-OXOPYRROLIDINE, N-BOC PROTECTED;TERT-BUTYL (2S)-2-PHENYL-4-OXOPYRROLIDINE-1-CARBOXYLATE;(S)-tert-Butyl 4-oxo-2-phenylpyrrolidine-1-carboxylate
    3. CAS NO:635724-46-8
    4. Molecular Formula: C15H19NO3
    5. Molecular Weight: 261.32
    6. EINECS: N/A
    7. Product Categories: Pyrrolidine series;Pyrrolidines;Ring Systems;Heterocyclic Building Blocks
    8. Mol File: 635724-46-8.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 385.6±42.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.147±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: 2-8°C
    8. Solubility: N/A
    9. PKA: -2.56±0.40(Predicted)
    10. CAS DataBase Reference: (2S)-2-PHENYL-4-OXOPYRROLIDINE, N-BOC PROTECTED(CAS DataBase Reference)
    11. NIST Chemistry Reference: (2S)-2-PHENYL-4-OXOPYRROLIDINE, N-BOC PROTECTED(635724-46-8)
    12. EPA Substance Registry System: (2S)-2-PHENYL-4-OXOPYRROLIDINE, N-BOC PROTECTED(635724-46-8)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 635724-46-8(Hazardous Substances Data)

635724-46-8 Usage

Uses

Used in Pharmaceutical Industry:
(2S)-2-PHENYL-4-OXOPYRROLIDINE, N-BOC PROTECTED is used as a key intermediate for the synthesis of various pharmaceuticals, leveraging its unique structure and reactivity to create new and useful molecules for medicinal applications.
Used in Agrochemical Industry:
In the agrochemical field, (2S)-2-PHENYL-4-OXOPYRROLIDINE, N-BOC PROTECTED is utilized as a precursor in the development of agrochemicals, contributing to the creation of innovative products for agricultural use.
Used in Organic Chemistry Research and Development:
(2S)-2-PHENYL-4-OXOPYRROLIDINE, N-BOC PROTECTED is employed as a valuable tool in organic chemistry research and development, where its BOC protection group allows for controlled reactivity in specific chemical transformations, facilitating the synthesis of complex molecules.

Check Digit Verification of cas no

The CAS Registry Mumber 635724-46-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,3,5,7,2 and 4 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 635724-46:
(8*6)+(7*3)+(6*5)+(5*7)+(4*2)+(3*4)+(2*4)+(1*6)=168
168 % 10 = 8
So 635724-46-8 is a valid CAS Registry Number.

635724-46-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl (2S)-4-oxo-2-phenylpyrrolidine-1-carboxylate

1.2 Other means of identification

Product number -
Other names (2S)-tert-butyl 4-oxo-2-phenylpyrrolidine-1-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:635724-46-8 SDS

635724-46-8Relevant articles and documents

Kinesin spindle protein (KSP) inhibitors. Part 2: The design, synthesis, and characterization of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP

Fraley, Mark E.,Garbaccio, Robert M.,Arrington, Kenneth L.,Hoffman, William F.,Tasber, Edward S.,Coleman, Paul J.,Buser, Carolyn A.,Walsh, Eileen S.,Hamilton, Kelly,Fernandes, Christine,Schaber, Michael D.,Lobell, Robert B.,Tao, Weikang,South, Victoria J.,Yan, Youwei,Kuo, Lawrence C.,Prueksaritanont, Thomayant,Shu, Cathy,Torrent, Maricel,Heimbrook, David C.,Kohl, Nancy E.,Huber, Hans E.,Hartman, George D.

, p. 1775 - 1779 (2007/10/03)

The evolution of 2,4-diaryl-2,5-dihydropyrroles as inhibitors of KSP is described. Introduction of basic amide and urea moieties to the dihydropyrrole nucleus enhanced potency and aqueous solubility, simultaneously, and provided compounds that caused mito

Prodrugs of mitotic kinesin inhibitors

-

Page/Page column 41-42, (2008/06/13)

The present invention relates to phosphate ester prodrugs of dihydropyrrole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention

Mitotic kinesin inhibitors

-

Page/Page column 39, (2008/06/13)

The present invention relates to dihydropyrrole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention is also related to compositions which comprise these compounds, and methods of using them to treat cancer in mammals.

MITOTIC KINESIN INHIBITORS

-

Page 151, (2008/06/13)

The present invention relates to dihydropyrrole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to compositions

MITOTIC KINESIN INHIBITORS

-

Page 66, (2010/02/04)

The present invention relates to dihydropyrazole compounds that are useful for treating cellular proliferative diseases, for treating disorders associated with KSP kinesin activity, and for inhibiting KSP kinesin. The invention also related to composition

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 635724-46-8